Moreover, in a mouse model of cholestasis-induced liver fibrosis, platelets are activated by HSCs and play an antifibrotic role by reducing collagen I deposition by HSCs through enhancing the HGF-MET signaling pathway [112]. This evidence concerns the gene MET and Hepatic fibrosis.